Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 1 of 1412345...10...Last »

FDA teams with medical companies in Puerto Rico to tackle shortages

The head of the U.S. Food and Drug Administration said the agency was working with several pharmaceutical and medical device companies in Puerto Rico to prevent shortages of medical products in the United States as it joins a massive effort to help rebuild the island that was ravaged by Hurricane Maria.

Read More »

China biotech’s ‘coming out party’ masks long road ahead

Investors are betting on China’s potential to feed the global pharmaceutical pipeline, putting a multi-billion-dollar price tag on a handful of stocks, even as the country struggles to close a huge R&D gap with the West.

Read More »

Sanofi invests 170 million euros in French vaccines facility

Sanofi is investing invest 170 million euros ($202 million) to expand its vaccines manufacturing site at Val-de-Reuil in north-western France, in a drive aimed at boosting the production of one of the company’s influenza vaccines.

Read More »

China to accept overseas trial data

China plans to accept data from overseas clinical trials to speed up approvals of drugs, a potential boon for international drugmakers as well as patients.

Read More »

Drug industry fails to win judicial review of new UK cost curbs

Britain’s pharmaceuticals industry failed to secure a judicial review of new cost curbs, which mean drugs costing NHS England more than 20 million pounds ($26 million) annually no longer get automatic funding.

Read More »

U.S. pressing India to avoid capping medical device prices, allow withdrawals

The United States is pressing India not to extend price caps on medical devices and wants New Delhi to allow firms to withdraw products from the market if they do not wish to sell at government determined rates, a U.S. trade official told Reuters.

Read More »

AbbVie, Amgen resolve Humira patent disputes

AbbVie announced today a global resolution of all intellectual property-related litigation with Amgen over Amgen’s proposed biosimilar adalimumab product.

Read More »

EU drugs watchdog warns of staff exodus if move from London botched

Europe’s drugs regulator could lose more than 70 percent of staff, making it unable to function, if politicians pick the wrong new home for the London-based agency, it warned on Tuesday.

Read More »

Japan health minister to consider U.S. drug firms’ views in pricing overhaul

Japan will weigh the concerns of U.S. drug firms in its efforts to complete by year-end a drastic revision of its drug-pricing system, aimed at reining in medical spending and cutting the public burden, the health minister said.

Read More »

Exclusive: Africa to get state-of-art HIV drugs for $75 a year

Makers of generic AIDS drugs will start churning out millions of pills for Africa containing a state-of-the-art medicine widely used in rich countries, after securing a multi-million dollar guarantee that caps prices at just $75 per patient a year.

Read More »

Nestle to cut jobs at French skin health R&D center

Nestle plans to cut up to 450 jobs at a Galderma research and development center in southern France, the Swiss company said.

Read More »

Bay Area Startup Arcus Biosciences Lands $307 Million+ Deal With Taiho Pharma

Arcus Biosciences announced it has inked an option and license deal with Taiho Pharmaceutical Co. to develop and commercialize product candidates in Arcus’s portfolio in Japan and specific Asian territories excluding China.

Read More »

Shire, Shionogi’s ADHD drug for adults clears late-stage trial in Japan

Shire Plc and Shionogi & Co. Ltd. said a drug to treat ADHD in adults had met its main goal in a late-stage trial in Japan, bringing it one step closer to approval in the world’s third-biggest market for ADHD treatments.

Read More »

France’s Servier to face trial over Mediator weight-loss drug

Drug maker Servier and the French drug regulator will face trial over weight-loss pill Mediator, believed to have caused at least 500 deaths in one of France’s worst health scandals, the prosecutor’s office said.

Read More »

UK report plans boost for life sciences as Brexit looms

The British government has rekindled its industrial strategy, unveiled earlier in 2017 to prepare the economy for Brexit, with plans to boost the country’s pharmaceuticals sector via fresh investments and public-private collaborations.

Read More »

Surgeons in France reattach woman’s arms after train accident

Surgeons re-attached a woman’s arms after they were severed by a train, a rare operation and a first in France in that both limbs were worked on at the same time.

Read More »

The FDA Calls Kyowa Hakko Kirin’s Lymphoma Drug a Breakthrough

The U.S. Food and Drug Administration granted its Breakthrough Therapy Designation to a drug that has been available to lymphoma patients in Japan for several years.

Read More »

India’s proposed pharma marketing rules hit legal roadblock

India’s plan to bring in marketing rules to curb unethical promotional practices in the country’s drug industry faces an indefinite delay after it hit a legal roadblock, marking a setback for public health groups.

Read More »

India grants Pfizer patent on pneumonia vaccine in blow to aid group

India granted Pfizer Inc. a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations.

Read More »

Philippines reports second outbreak of bird flu

The Philippines found a second outbreak of bird flu in another province in the main Luzon island, Agriculture Secretary Emmanuel Pinol said, a week after reporting the country’s first case of the poultry disease.

Read More »

Page 1 of 1412345...10...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2017 Focus: Manufacturer of the Year, Top 50 Pharma, HBA and more!


Ad Right Bottom

Main Navigation